Is BRTX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for BRTX. It does not provide personalized investment advice.

BRTX (BioRestorative Therapies, Inc. Common Stock (NV)) Stock Analysis - Financials

BioRestorative Therapies, Inc. Common Stock (NV) (BRTX) is a publicly traded Healthcare sector company. As of September 4, 2026, BRTX trades at $0.14 with a market cap of $3.97M and a P/E ratio of -0.09. BRTX moved +1.25% today. Year to date, BRTX is -87.62%; over the trailing twelve months it is -90.75%. Its 52-week range spans $0.14 to $2.55. Rallies surfaces BRTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are BRTX's key financials?

BRTX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. BRTX recently traded at $0.14. Market cap is $3.97M. P/E ratio is -0.09. Revenue is $359.70K.

BRTX Key Metrics

Key financial metrics for BRTX
Metric	Value
Price	$0.14
Market Cap	$3.97M
P/E Ratio	-0.09
EPS	$-1.58
Dividend Yield	0.00%
52-Week High	$2.55
52-Week Low	$0.14
Volume	521.89K
Avg Volume	0
Revenue (TTM)	$359.70K
Net Income	$-14.24M
Gross Margin	93.37%

BRTX Analyst Consensus

BRTX analyst coverage data. Average price target: $0.00.

Common questions about BRTX

What are BRTX's key financials?: BRTX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. BRTX recently traded at $0.14. Market cap is $3.97M. P/E ratio is -0.09. Revenue is $359.70K.
Is BRTX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for BRTX. It does not provide personalized investment advice.